THE EFFECT OF PUMPKIN (CUCURBITA PEPO L) SEEDS  AND L-ARGININE SUPPLEMENTATION ON SERUM LIPID CONCENTRATIONS IN ATHEROGENIC RATS by Abuelgassim, Abuelgassim O & AL-showayman, Showayman I A
Abuelgassim and Al-Showayman Afr J Tradit Complement Altern Med. (2012) 
9(1):131‐137 
http://dx.doi.org/10.4314/ajtcam.v9i1.18 
131
THE EFFECT OF PUMPKIN (CUCURBITA PEPO L) SEEDS  AND L-ARGININE 
SUPPLEMENTATION ON SERUM LIPID CONCENTRATIONS IN ATHEROGENIC RATS 
 
Abuelgassim O. Abuelgassim 1 and Showayman I A AL-showayman 1 
 
1Department of Biochemistry, King Saud University 
P.O.Box 2455, Riyadh 11451, Saudi Arabia 
E-mail : gassim@ksu.edu.sa  
 
 
Abstract 
 
The present study aimed to examine  the effect of pumpkin   (Cucurbita pepo L.) seeds supplementation on 
atherogenic diet-induced atherosclerosis.  Rat were divided into two main groups , normal control and atherogenic control  
rats , each group composed of three subgroups one of them supplemented with 2% arginine in drinking water and the other 
supplemented with pumpkin seeds in diet  at a concentration equivalent to 2% arginine. Supplementation continued for 37 
days. Atherogenic rats supplemented with pumpkin seeds showed  a significant decrease (p<0.001) in their serum 
concentrations of total cholesterol and LDL – C  as they dropped from 4.89 mmol / L to 2.55 mmol /L and from 3.33 mmol / 
L to 0.70 mmol / L  respectively. Serum concentrations of  HDL-C were also significantly elevated in  the same group. 
Although, atherogenic rats supplemented with 2% arginine showed significant increase in serum concentration of HDL-C, no 
significant changes were observed in their serum concentrations of total cholesterol and LDL-C. Our results showed that 
treatment of atherogenic rats with pumpkin seeds significantly decreased serum concentrations of TC and LDL-C. Our 
findings suggest that pumpkin seeds supplementation has a protective effect against atherogenic rats and this protective effect 
was not attributed to the high arginine concentrations in pumpkin seeds.  
 
Key words: arginine, low density lipoprotein, cholesterol,  atherosclerosis,   nitric oxide, C-reactive protein. 
 
 
Introduction 
 
Cardiovascular disease (CVD) continues to be one of the most important health problems and the leading cause of 
death in many countries all over the world (McDonnell et al., 2009). Several studies have reported that low-density 
lipoprotein (LDL) oxidation plays a principal role in the pathogenesis of atherosclerosis, and lowering LDL-cholesterol 
reduces the risk of the disease and also reduces morbidity and mortality (Chong and Bachenheimer , 2000). Tremendous 
interest has been focused in finding natural substances present in foods or medicinal plants that decrease the risk of 
cardiovascular and degenerative diseases by reduction of oxidative stress and counteraction of macromolecular oxidation 
(Magalhaes et al., 2009). 
Pumpkin seeds is a rich source of  proteins, polyunsaturated fatty acids (Applequist et al., 2006 ; Sabudak, 2007 ), 
phytosterols (Phillips et al ., 2005 ; Ryan et al., 2007 ) , antioxidant vitamins, such as carotenoids and tocopherol (Stevenson 
et al ., 2007 ) and trace elements, such as selenium and zinc (Glew et al ., 2006 ). Pumpkin seeds have many health benefits, 
as pumpkin seed oil can retard the progression of hypertension and reduce hypercholesterolemia (Al-Zuhair et al ., 1997 ), 
protect against arthritis (Fahim et al., 1995 ) and possess a hypoglycemic activity (Caili et al ., 2006 ).  Treatment of 
hypertensive rats with felodipine or captopril separately or combined with pumpkin seed oil resulted in improvement of free 
radical scavengers in the heart and kidney tissues (Al-Zuhair et al., 2000). Diets rich in pumpkin seeds were also reported to 
be associated with lower levels of gastric, breast, lung, and colorectal cancer (Huang et al., 2004). Pumpkin seeds are capable 
of causing the evacuation of parasitic intestinal worms (Applequist et al., 2006; Caili et al., 2006). Several investigations 
showed that L- arginine has an efficient effect in reducing lesion size, aortic intimal thickening, coronary intimal plaques, 
reduced homocysteine levels, and inhibit lipid peroxidation (Dhawan et al ., 2005; West et al ., 2005; Rasmusen et al ., 2007). 
Although, it has been reported that pumpkin seeds are rich in arginine (Glew et al ., 2006 ) however, the present work  
attempts to study the effect of pumpkin seeds administration on serum lipid concentrations in atherogenic rats. 
 
 
 
Materials and Methods   
Materials  
  
Pumpkin (Cucurbita sp.) seeds were purchased from local market. Atherogenic diet (for atherogenesis induction) 
was purchased from ICN pharmaceuticals (Costa Mesa,CA-USA). Kits for the assay of total cholesterol (TC), low density 
lipoprotein-cholesterol (LDL-C), high density lipoprotein-cholesterol (HDL-C), triglycerides (TG), and glucose were 
purchased from Human GmbH (Wiesbaden , Germany). C reactive protein (CRP) kit was obtained from R&D Systems, Inc. 
(Minneapolis, MN, USA). Nitric oxide (NO) kit was purchased from BioVendor - Laboratorni Medicina a.s.(Modrice , Czech 
Republic). All other chemicals used were ACS grade. 
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Animals  
 
Male Wistar rats (110-160 g) were obtained from the animal house, Faculty of Pharmacy, King Saud University, 
Riyadh, Saudi Arabia. Rats were divided into 6 groups. Group 1 consist of rats that were kept on standard laboratory diet; this 
group was used as normal controls (NC). Group 2 consist of normal rats that were kept on 2% arginine in drinking water 
(NC+Arg). Group 3 consist of  normal rats that pumpkin seeds (PS) were mixed with the standard laboratory diet (57 g 
Standard laboratory diet + 43 g P.S ), this group designated as ( NC +PS ). Group 4 consisted of rats that were kept only on 
atherogenic diet (AT). Group 5 consisted of rats that were kept on atherogenic diet and treated with 2% arginine in drinking 
water (AT+Arg). Group 6 consisted of rats in which pumpkin seeds (PS) were mixed with the atherogenic diet (57 g 
atherogenic diet + 43 g P.S ), this group was designated as ( AT+PS ). Animals were housed in normal conditions 
(Temperature 22 ± 2 °C, a minimum relative humidity of 40%, 12 h light/dark cycle). All diets were given for 37 days with 
free access to water. Body weight and food intake of controls and treated rats were recorded daily. All animal experiments 
were carried out in accordance with King Saud University Ethical Committee Acts. At the end of the experimental period and 
after 12 h of fasting, aliquots of blood samples from all groups were collected in plain tubes. Serum samples were separated 
from cells by centrifugation at 5000g for 10 min in a refrigerated centrifuge and were kept at - 80 °C until analysis.  
 
Methods 
Measurement of serum concentrations of lipids and glucose 
 
Glucose, total cholesterol (TC), triglycerides (TG), high density lipoprotein-cholesterol( HDL-C), and low density 
lipoprotein-cholesterol (LDL-C) were estimated  in serum samples by standard enzymatic methods using Human kits 
(Barham  and Trinder, 1972 ; Richmond 1973 ; Schettler and Nussel, 1975; Izawa et al., 1997 ; Okada et al .,1998) 
respectively  . The concentrations of these parameters were measured in a Humalyzer  model 3000. 
 
Measurement of serum concentration of C reactive protein 
 
C reactive protein (CRP) levels in serum were determined by the sandwich ELISA method using a commercially 
available kit from R&D Systems, Inc. (Minneapolis, MN, USA). Appropriate controls and standards as specified by the kit 
manufacturer were used. Serum CRP concentrations were expressed as microgram per milliliter serum. 
 
Measurement of total nitrates and nitrites    
 
Nitric oxide (NO) concentrations in serum were determined by measuring accumulation of nitrates and nitrites 
based on Griess reaction (Moshage et al ., 1995) according to the procedures of a commercially available kit from BioVendor 
- Laboratorni Medicina a.s.(Modrice , Czech Republic) concentrations were expressed as µmol / L . 
 
Measurement of serum arginine concentrations 
 
Serum arginine concentrations were determined using the method of (Bacchus and London, 1971) with 
modifications. To a 0.02 ml serum sample, 0.2 ml NaOH 2 mol / L, 0.8 ml 0.01g % 8- hydoxyquinoline and 0.4 ml 0.1g % N- 
bromosuccinimide were added in that order. The solution was thoroughly mixed and absorbance read at 500 nm after 2 min 
incubation. Absorbance readings at 500 nm were compared with an arginine standard curve to estimate concentrations. A 2.5 
mmol/L L-arginine solution was used as standard. 
 
Measurement of arginine and protein concentrations in   pumpkin seeds  
 
100 g of dry pumpkin seeds powder were extracted twice with petroleum ether overnight. Filtrates collected by 
centrifugation at 15000 rpm for 10 min were discarded and the residues were divided into 2 parts and their weights were 
recorded. The first part was resuspended in distilled water and the final volume was recorded. Appropriate serial dilutions of 
5, 10, 25, 50 and 100 were made. The protein content of diluted samples was assayed by Biuret method (Gornall et al., 1949). 
6 N HCl was added to the second part of the residue and the suspension was left overnight , filtrates were collected and serial 
dilutions were made as above. Arginine content of diluted samples was determined by the  same protocol as mentioned  
earlier . 
 
Data analysis 
 
The data presented in this investigation are expressed as means ± standard error of the mean (SEM) and 
comparison between experimental and corresponding control rats was made by using Student’s t-tests. The probability value 
of <0.05 was considered significant. 
 
 
Results 
Animal weights, food intake, and water ingestion 
 
Although, all studied groups showed a significant increase in their final body weights, however, group 2 (NC + arg) and  
group 6 (AT + PS) that were treated with the same concentration of arginine (2%) exhibited the most significant   
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Figure 1: Standard curve of L-arginine.  Working standard concentration is 2.5 mmol / L 
 
Table 1:General characteristics of control and atherogenic rats treated with arginine and pumpkin seeds 
 
 
Characteristics 
 
St.Lab.diet 
 
St.Lab.diet 
+ 
2% Arg. 
 
St.Lab.diet 
+ 
P.S 
 
AT. Diet 
 
AT. diet 
+ 
2% Arg. 
 
AT. diet 
+ 
P.S 
 
Initial B.Wt. ( g ) 
 
112.0 ±1.02 
( 10 ) 
 
110.3 ±0.69 
( 11 ) 
 
114 ±0.6 
( 14 ) 
 
117 ±0.67 
( 14 ) 
 
115.6 ±0.64 
( 13 ) 
 
116.14 ±1.09 
( 12 ) 
 
Final B.Wt. ( g ) 
 
266.9 ±1.07 
( 10 ) 
 
251.33 ±1.33 † 
( 11 ) 
 
 
261.6 ± 1.07** 
( 14 ) 
 
 
274.3 ±1.38 * 
( 14 ) 
 
 
281.7 ±0.96 * 
( 13 ) 
 
 
307.1 ±1.24 † 
( 12 ) 
 
 
Food Intake 
 ( g / day ) 
 
 
20.04 ±0.39 
( 10 ) 
 
16.83 ±0.62 † 
( 11 ) 
 
 
16.52 ±0.94 † 
( 14 ) 
 
 
18.29 ±0.45 † 
( 14 ) 
 
 
21.44 ±0.35 † 
( 13 ) 
 
 
19.33 ±0.55 
( 12 ) 
 
 
Water consumption 
 ( ml / day ) 
 
34.97 ±1.27 
( 10 ) 
 
35.71 ±1.36 
( 11 ) 
 
 
35.64 ±1.09 
( 14 ) 
 
 
43.59 ±1.10 † 
( 14 ) 
 
 
50.86 ±1.22 † 
( 13 ) 
 
 
42.0 ± 1.31  
( 12 ) 
 
Data are expressed as mean±SEM, with number of rats given in parentheses. As compared with matched groups, * p<0.01 ;  
** p< 0.02 ; † p<0.001(student t test).  
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Table 2: Serum concentrations of total cholesterol (TC), triglycerides (TG), low-density lipoprotein-cholesterol (LDL-C), 
                and high-density lipoprotein-cholesterol (HDL-C), in control and atherogenic rats treated with arginine and  
                pumpkin seeds 
 
 
Parameters 
 
St.Lab.diet 
 
St.Lab.diet 
+ 
2% Arg. 
 
St.Lab.diet 
+ 
P.S 
 
AT. diet 
 
AT. diet 
+ 
2% Arg. 
 
AT. diet 
+ 
P.S 
 
Total cholesterol  
 ( mmol / L ) 
 
1.43 ±0.07 
( 16 ) 
 
1.70 ±0.05 
( 15 ) 
 
1.88 ±0.04 * 
(15 ) 
 
4.89 ±0.14 † 
( 12 ) 
 
5.66 ±0.12 
( 13 ) 
 
2.55 ±0.06 † 
( 13 ) 
 
Triglycerides  
 ( mmol / L ) 
 
1.04 ±0.03 
( 16 ) 
 
0.91 ±0.02 
( 15 ) 
 
1.96 ±0.06 † 
( 14 ) 
 
1.72 ±0.08 † 
( 12 ) 
 
1.42 ±0.04 
( 15 ) 
 
1.85 ±0.06 
( 13 ) 
LDL – C 
 ( mmol / L ) 
 
0.60 ±0.03 
( 14 ) 
 
0.52 ±0.02 
( 13 ) 
 
0.49 ±0.02 
( 10 ) 
 
3.33 ±0.07 † 
( 11 ) 
 
2.71 ±0.06 
( 15 ) 
 
0.70 ±0.03 † 
( 14 ) 
HDL – C 
 ( mmol / L ) 
 
0.44 ± 0.02 
( 13 ) 
 
0.48 ±0.02 
( 15 ) 
 
0.47 ±0.01 
( 14 ) 
 
0.43 ±0.01 
( 12 ) 
 
0.96 ±0.03 † 
( 15 ) 
 
0.89±0.03 † 
( 15 ) 
Data are expressed as mean±SEM, with number of rats given in parentheses. As compared with matched groups, * p<0.05 ;  
† p<0.001 (student t test).  
 
 
 
 
Table 3:  Serum concentrations of glucose , arginine , C- reactive protein (CRP) ,and nitric oxide (NO)  in control and 
               atherogenic rats treated with arginine and pumpkin seeds 
                 
 
Parameters 
 
St.Lab.diet 
 
St.Lab.diet 
+ 
2% Arg. 
 
St.Lab.diet 
+ 
P.S 
 
AT. diet 
 
AT. diet 
+ 
2% Arg. 
 
AT. diet 
+ 
P.S 
 
Glucose 
 ( mmol / L ) 
 
6.19± 0.18  
(14) 
 
6.83± 0.14 
(15) 
 
 
 
7.03± 0.20 * 
(14) 
 
 
 
6.58± 0.12 
(10) 
 
 
 
6.63± 0.17 
(15) 
 
 
 
6.95± 0.14 
(12) 
 
 
 
Arginine 
 (mg / dL ) 
 
9.23± 0.29 
(12) 
 
4.69± 0.13 † 
(10) 
 
 
 
5.83± 0.16 † 
(10) 
 
 
 
16.54± 0.30 † 
(10) 
 
 
 
16.07± 0.26 
(11) 
 
 
 
15.59± 0.33 
(12) 
 
 
 
CRP 
 (µg / ml ) 
 
488.24± 23.85 
(13) 
 
477.26± 20.20 
(12) 
 
 
483.67± 18.37 
(11) 
 
 
498.26± 19.16 
(9) 
 
 
474.10± 21.37 
(11) 
 
 
479.61± 15.36 
(12) 
 
 
NO 
µmol / L 
 
38.79± 2.26 
(7) 
 
40.43± 2.42 
(7)   
 
41.91± 2.66 
(7)  
 
24.52± 1.64 ‡ 
(7) 
 
 
30.28± 1.75 * 
(7) 
 
14.58± 0.84 † 
(7) 
Data are expressed as mean±SEM, with number of rats given in parentheses. As compared with matched groups, * p<0.02 ;  
‡ p<0.005 ;  † p<0.001  (student t test). 
 
 
 
increase in their final body weights ( p<0.001 )  when compared to their matched groups. Food intake was significantly 
decreased (p<0.001) in  control rats treated with either 2% arginine or pumpkin seeds. On the other hand, no significant 
change was observed in food intake of atherogenic rats treated with pumpkin seeds (Table 1). Ingested water was 
significantly increased in rats kept on atherogenic diet (AT) as compared to normal control rats (p<0.001). 
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Protein and arginine concentrations in pumpkin seeds 
 
The protein concentration in pumpkin seeds was estimated to be 39.5g / 100 g PS  using Biuret method and BSA as 
standard at a concentration of 5 mg / ml. Arginine concentration in pumpkin seeds was estimated to be 4.7 g / 100 g PS  
using the method in Materials and Methods Section  and standard arginine at a concentration  of 2.5 mmol / L (Figure 1). 
 
Changes in serum lipid concentrations 
 
Both of TC and LDL-C concentrations were significantly decreased in atherogenic rats treated with pumpkin seeds, 
as total cholesterol  concentrations decreased by 48% from 4.89 mmol / L to 2.55 mmol /L ( P< 0.001 ), whereas LDL –C 
concentrations amazingly decreased by 79% from 3.33 mmol / L to 0.70 mmol / L  (Table 2). No significant changes were 
observed in serum TG concentrations when atherogenic rats treated with either 2% arginine or pumpkin seeds, in contrast,  a 
significant increase  was noticed  in the same parameter with control rats treated with pumpkin seeds (p<0.001) . A 
significant increase (p<0.001) was observed in serum HDL-C concentrations of atherogenic rats supplemented with either 2% 
arginine or pumpkin seeds. 
 
Changes in serum concentrations of glucose, arginine, CRP and NO 
 
Serum glucose concentrations in atherogenic rats were not significantly different from that of their matched control 
rats. Although no changes were observed in serum glucose concentrations of atherogenic rats supplemented with either 2% 
arginine or pumpkin seeds, however, control rats supplemented with pumpkin seeds showed  a significant increase in serum 
glucose concentrations (p<0.02) (Table 2). 
Atherogenic rats showed a significant increase (p<0.001) in serum arginine levels compared to their matched 
control rats (16.54 and 9.23 mg / dl respectively). Control rats supplemented with either 2% arginine or pumpkin seeds 
showed a significant decrease (p<0.001) in serum arginine concentrations, conversely, no significant changes were noticed in 
serum arginine levels of treated atherogenic rats. Serum levels of CRP in atherogenic rats were not significantly different 
from that in control rats. Supplementation with either 2%arginine or pumpkin seeds had no significant effect on serum CRP 
levels of treated groups when compared to their matched controls (Table 3). Serum concentrations of nitric oxide were 
markedly decreases in atherogenic rats (p< 0.005) compared to their matched control rats (24.52 and 38.79 µmol / L 
respectively). Control rats supplemented with either 2% arginine or pumpkin seeds showed no changes in serum NO 
concentrations, however, atherogenic rats treated with 2% arginine showed a significant increase in serum NO levels as it 
increased from 24.52 to 30.28 µmol / L. On the other hand, atherogenic rats supplemented with pumpkin seeds showed a 
markedly decrease in serum NO concentrations (Table 3). 
 
 
Discussion 
 
Results of the present study showed that atherogenic rats supplemented with pumpkin seeds showed a significant 
decrease in their serum concentrations of TC and LDL-C, this decrease was 48% and 79% respectively (p< 0.001). Although, 
our first assumption for the role of L-arginine in the prevention of atherogenesis progress was based on the premise that 
arginine exerts its effect through facilitating increase of endothelial NO formation as reported by several investigators (Cooke 
et al., 1992; Brandes et al., 2000), however, our findings showed that supplementation of L-arginine at a concentration of 2% 
in drinking water did not significantly change the serum concentrations of TC and LDL-C in atherogenic rats. Lam et al., 
(2008)  reported that unsaturated fatty acids inhibit the activity of intestinal acyl coenzyme A: cholesterol acyltransferase 
(ACAT), the rate-limiting step in cholesterol absorption, from this view, and  as a rich source of  poly unsaturated fatty acids, 
the effect of pumpkin seeds on the serum concentrations of TC  in atherogenic rats could be explained . 
Our finding that pumpkin seeds markedly decreased the serum concentrations of LDL-C in atherogenic rats is in a 
full agreement with that of  Makni et al. (2008) who reported that flax and pumpkin seed mixture significantly decreased 
LDL/HDL ratio and had anti-atherogenic and hepatoprotective effects. In addition, the serum arginine levels were 
significantly increased in atherogenic rats compared to normal control rats (16.54 and 9.23 mg / dl respectively). This 
increase in serum arginine levels in atherogenic rats could be to due to the attenuation of arginine uptake through cationic 
amino acid transporter-1 as reported by Schwartz et al. (2007). Both groups of atherogenic rats supplemented with 2% 
arginine and pumpkin seeds showed no significant changes in their serum arginine concentrations, this also could be 
explained by the attenuation of arginine uptake through cationic amino acid transporter-1. Our results showed no association 
between serum concentrations of  arginine and CRP in all groups of study , this finding contrasts the report by (Wells et al., 
2005) which concluded the relationship between arginine  intake and CRP levels in humans, this difference could be due to 
species differences . 
Although, serum arginine levels were significantly increased in atherogenic rats compared to control rats 
(p<0.001), serum concentrations of nitric oxide significantly decreased (Table 3), this decrease in NO may be due to the 
increased concentrations of  endogenous asymmetric dimethylarginine (ADMA), an inhibitor of endothelial nitric oxide 
synthase (eNOS). Based on this fact, our findings coincide with the uncoupling mechanism of eNOS in atherosclerotic 
endothelial dysfunction reported by (Yang and Ming, 2006). Unexpectedly, atherogenic rats supplemented with pumpkin 
seeds showed  a significant decrease in serum NO concentrations as it dropped by 41%  from 24.52 to 14.58 µmol / L  
(p<0.001), a rational explanation could be that pumpkin seeds consist of palmitic acid and linoleic acid at a concentration of  
38.6 and 92.0 mg / g dry weight respectively (Glew et al ., 2006 ), and these fatty acids are  capable to  inducing 
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dephosphorylation and/or inactivation of eNOS on Ser1177 leading to a decrease of the enzyme functional activity and 
thereafter reducing the level of NO (Guo et al ., 2008). 
In conclusion, the current study showed that a pumpkin seed has a beneficial effect on atherogenic rats as it caused 
a significant reduction in serum concentrations of TC and LDL-C and increased the serum levels of HDL-C. Further studies 
are needed to elucidate the mechanism by which a pumpkin seed has such hypocholesterolaemic effect.  Our future work will 
be focused on separation of active ingredients and recognition of their specific activities, and will target the effect of pumpkin 
seeds on 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. 
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